Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Sarcoma 1Breast 1

Conditions

Breast Neoplasms 66Neutropenia 16Triple Negative Breast Neoplasms 8Breast Neoplasms, Male 6Inflammatory Breast Neoplasms 4Ovarian Neoplasms 3Lung Neoplasms 3Neoplasms 2Febrile Neutropenia 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Sarcoma 1Recurrence 1Pancreatic Neoplasms 1Pain 1Melanoma 1Lymphoma, Non-Hodgkin 1Locally Advanced Breast Cancer 1HER2-positive Breast Cancer 1HER2-Positive Early Stage Breast Cancer 1Fever 1Early Stage Breast Cancer 1Colorectal Neoplasms 1Chemotherapy-Induced Febrile Neutropenia 1Carcinoma, Renal Cell 1Carcinoma 1Breast Diseases 1Breast Cancer Metastatic 1Breast Cancer Female 1Adenocarcinoma 1

Interventions

pembrolizumab 24Nivolumab 7Early Intervention, Educational 7Methods 6durvalumab 5aldesleukin 5Trastuzumab 5Paclitaxel 5Fulvestrant 5Carboplatin 5atezolizumab 4Surveys and Questionnaires 4Patient Navigation 4Docetaxel 4Cyclophosphamide 4Biopsy 4fludarabine 3Mass Screening 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Interleukin-2 3Gene Expression Profiling 3Fluorouracil 3Educational Status 3Bevacizumab 3tremelimumab 2spartalizumab 2sargramostim 2palbociclib 2fludarabine phosphate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × pegfilgrastim × Breast × Clear all
NCT07064018 2025-07-14

Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

University of California, Irvine

Phase 1/2 Recruiting
67 enrolled
BreastGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Ovarian Neoplasms, Sarcoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡